300 related articles for article (PubMed ID: 24636481)
1. A rationale for chemoradiation (vs radiotherapy) in salivary gland cancers? On behalf of the REFCOR (French rare head and neck cancer network).
Cerda T; Sun XS; Vignot S; Marcy PY; Baujat B; Baglin AC; Ali AM; Testelin S; Reyt E; Janot F; Thariat J
Crit Rev Oncol Hematol; 2014 Aug; 91(2):142-58. PubMed ID: 24636481
[TBL] [Abstract][Full Text] [Related]
2. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.
Schoenfeld JD; Sher DJ; Norris CM; Haddad RI; Posner MR; Balboni TA; Tishler RB
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):308-14. PubMed ID: 21075557
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma.
Tanvetyanon T; Qin D; Padhya T; McCaffrey J; Zhu W; Boulware D; DeConti R; Trotti A
Arch Otolaryngol Head Neck Surg; 2009 Jul; 135(7):687-92. PubMed ID: 19620591
[TBL] [Abstract][Full Text] [Related]
4. [Rare tumors of the head and neck; on behalf of the REFCOR, the French Network of rare head and neck tumors].
Baujat B; Thariat J; Baglin AC; Costes V; Testelin S; Reyt E; Janot F;
Bull Cancer; 2014 May; 101(5):411-23. PubMed ID: 24886891
[TBL] [Abstract][Full Text] [Related]
5. Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but Not overall survival in patients with salivary gland adenoid cystic carcinoma-a propensity score matched study.
Hsieh CE; Lin CY; Lee LY; Yang LY; Wang CC; Wang HM; Chang JT; Fan KH; Liao CT; Yen TC; Fang KH; Tsang YM
Radiat Oncol; 2016 Mar; 11():47. PubMed ID: 27000157
[TBL] [Abstract][Full Text] [Related]
6. Update and perspectives on non-surgical treatment of salivary gland malignancies.
Airoldi M; Cortesina G; Giordano C; Pedani F; Cavalot A; Marcato P; Beatrice F; Bumma C
Acta Otorhinolaryngol Ital; 2003 Oct; 23(5):368-76. PubMed ID: 15108487
[TBL] [Abstract][Full Text] [Related]
7. Systemic therapies for recurrent and/or metastatic salivary gland cancers.
Vattemi E; Graiff C; Sava T; Pedersini R; Caldara A; Mandarà M
Expert Rev Anticancer Ther; 2008 Mar; 8(3):393-402. PubMed ID: 18366287
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancy.
Langer CJ; Duffy K; Horwitz EM; Litwin S; Rosvold E; Schol J; Keenan E; Nicolaou N; Friedman CD; Ridge JA
Cancer Invest; 2006 Mar; 24(2):164-73. PubMed ID: 16537186
[TBL] [Abstract][Full Text] [Related]
9. Concurrent chemoradiotherapy for locoregionally advanced salivary gland malignancies.
Rosenberg L; Weissler M; Hayes DN; Shockley W; Zanation A; Rosenman J; Chera B
Head Neck; 2012 Jun; 34(6):872-6. PubMed ID: 22127998
[TBL] [Abstract][Full Text] [Related]
10. [Malignant salivary gland tumors. Effect of histology and site on prognosis].
Chilla R; Casjens R; Eysholdt U; Droese M
HNO; 1983 Aug; 31(8):286-90. PubMed ID: 6629867
[TBL] [Abstract][Full Text] [Related]
11. Management of salivary gland tumors.
Andry G; Hamoir M; Locati LD; Licitra L; Langendijk JA
Expert Rev Anticancer Ther; 2012 Sep; 12(9):1161-8. PubMed ID: 23098116
[TBL] [Abstract][Full Text] [Related]
12. Radiation therapy for patients of malignant salivary gland tumors with positive surgical margins.
Sakata K; Aoki Y; Karasawa K; Nakagawa K; Hasezawa K; Muta N; Terahara A; Onogi Y; Sasaki Y; Akanuma A
Strahlenther Onkol; 1994 Jun; 170(6):342-6. PubMed ID: 8023243
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy of carboplatin and paclitaxel for advanced/metastatic salivary gland carcinoma patients: differences in responses by different pathological diagnoses.
Nakano K; Sato Y; Sasaki T; Shimbashi W; Fukushima H; Yonekawa H; Mitani H; Kawabata K; Takahashi S
Acta Otolaryngol; 2016 Sep; 136(9):948-51. PubMed ID: 27094013
[TBL] [Abstract][Full Text] [Related]
14. [Salivary gland tumors in children].
Thariat J; Vedrine PO; Orbach D; Marcy PY; Badoual C; Butori C; Teissier N; Toussaint B; Castillo L
Bull Cancer; 2011 Jul; 98(7):847-55. PubMed ID: 21690035
[TBL] [Abstract][Full Text] [Related]
15. Management of salivary gland carcinomas - a review.
Wang X; Luo Y; Li M; Yan H; Sun M; Fan T
Oncotarget; 2017 Jan; 8(3):3946-3956. PubMed ID: 27992367
[TBL] [Abstract][Full Text] [Related]
16. [Salivary duct carcinoma of the sublingual gland--a case report].
Sartorius C; Gille F; Bédrossian-Pfingsten J; Kempf HG
Laryngorhinootologie; 2006 Jul; 85(7):517-9. PubMed ID: 16586279
[TBL] [Abstract][Full Text] [Related]
17. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies.
Dodd RL; Slevin NJ
Oral Oncol; 2006 Sep; 42(8):759-69. PubMed ID: 16757203
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas.
Prestwich RJ; Öksüz DÇ; Dyker K; Coyle C; Şen M
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e237-43. PubMed ID: 21620580
[TBL] [Abstract][Full Text] [Related]
19. Minor salivary gland tumors of the oral cavity: a case series with review of literature.
Vaidya AD; Pantvaidya GH; Metgudmath R; Kane SV; D'Cruz AK
J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S111-5. PubMed ID: 22322728
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy of salivary gland tumours.
Larnaudie A; Marcy PY; Delaby N; Costes Martineau V; Troussier I; Bensadoun RJ; Vergez S; Servagi Vernat S; Thariat J
Cancer Radiother; 2022; 26(1-2):213-220. PubMed ID: 34953702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
